VTAL — Justera Health Cashflow Statement
0.000.00%
Last trade - 00:00- CA$0.80m
- CA$1.02m
- CA$1.91m
Annual cashflow statement for Justera Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 13 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.052 | -0.072 | -10.2 | -5.25 | -2.98 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.04 | 0.045 | 6.37 | 1.35 | -0.709 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.002 | 0.009 | 1.29 | 1.72 | 2.52 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.01 | -0.018 | -0.501 | -1.07 | -0.814 |
| Capital Expenditures | — | — | -0.797 | -0.118 | -0.236 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | 0.118 | 0.583 | -0.124 |
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | — | -0.679 | 0.465 | -0.36 |
| Financing Cash Flow Items | — | — | 0.025 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.01 | 0.018 | 0.942 | 0.835 | 0.832 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0 | 0 | -0.238 | 0.23 | -0.343 |